| Date Filed | Type | Description |
| 10/04/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/10/2023 |
8-K
| Quarterly results |
| 07/27/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 07/27/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 07/17/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 07/06/2023 |
4
| Gikakis Nicolas (Director) has filed a Form 4 on AETHLON MEDICAL INC|
Txns:
| Granted 195,414 shares
@ $0 |
|
| 07/06/2023 |
3
| Gikakis Nicolas (Director) has filed a Form 3 on AETHLON MEDICAL INC |
| 07/06/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 07/03/2023 |
4
| Shah Chetan (Director) has filed a Form 4 on AETHLON MEDICAL INC|
Txns:
| Paid exercise price by delivering 11,628 shares
@ $0.36, valued at
$4.2k
|
|
| 07/03/2023 |
4
| BROENNIMAN EDWARD G (Director) has filed a Form 4 on AETHLON MEDICAL INC|
Txns:
| Paid exercise price by delivering 11,628 shares
@ $0.36, valued at
$4.2k
|
|
| 06/28/2023 |
10-K
| Annual Report for the period ended March 31, 2023 |
| 06/28/2023 |
8-K
| Quarterly results |
| 05/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2023 |
8-K
| Quarterly results |
| 03/31/2023 |
4
| Shah Chetan (Director) has filed a Form 4 on AETHLON MEDICAL INC|
Txns:
| Paid exercise price by delivering 3,425 shares
@ $0.385, valued at
$1.3k
|
|
| 03/31/2023 |
4
| BROENNIMAN EDWARD G (Director) has filed a Form 4 on AETHLON MEDICAL INC|
Txns:
| Paid exercise price by delivering 3,425 shares
@ $0.385, valued at
$1.3k
|
|
| 02/13/2023 |
10-Q
| Quarterly Report for the period ended December 31, 2022 |
| 02/13/2023 |
8-K
| Quarterly results |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
3
| Arnold Lee D (Chief Scientific Officer) has filed a Form 3 on AETHLON MEDICAL INC |
| 12/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/14/2022 |
8-K
| Quarterly results |
| 10/27/2022 |
8-K
| Quarterly results |
| 10/04/2022 |
4
| BROENNIMAN EDWARD G (Director) has filed a Form 4 on AETHLON MEDICAL INC|
Txns:
| Paid exercise price by delivering 6,849 shares
@ $0.582, valued at
$4k
|
|
| 10/04/2022 |
4
| Shah Chetan (Director) has filed a Form 4 on AETHLON MEDICAL INC|
Txns:
| Paid exercise price by delivering 6,849 shares
@ $0.582, valued at
$4k
|
|
| 09/29/2022 |
8-K
| Quarterly results |
|